LBA-4 Initial data from the phase 3 KEYNOTE-811 study of trastuzumab and chemotherapy with or without pembrolizumab for HER2-positive metastatic gastric or gastroesophageal junction (G/GEJ) cancer
Titel:
LBA-4 Initial data from the phase 3 KEYNOTE-811 study of trastuzumab and chemotherapy with or without pembrolizumab for HER2-positive metastatic gastric or gastroesophageal junction (G/GEJ) cancer
Auteur:
Janjigian, Y. Kawazoe, A. Weber, P. Luo, S. Lonardi, S. Kolesnik, O. Barajas, O. Bai, Y. Shen, L. Tang, Y. Wyrwicz, L. Shitara, K. Qin, S. Van Cutsem, E. Tabernero, J. Li, L. Shih, C. Bhagia, P. Chung, H.